Carefully consider the potential benefits and risks of Voltaren® (diclofenac sodium enteric-coated tablets) and other treatment options before deciding to use Voltaren (diclofenac sodium) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

Voltaren (diclofenac sodium) is indicated:

• For relief of the signs and symptoms of osteoarthritis
• For relief of the signs and symptoms of rheumatoid arthritis
• For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis

Carefully consider the potential benefits and risks of Voltaren® (diclofenac sodium) (diclofenac sodium enteric-coated tablets) and other treatment options before deciding to use Voltaren (diclofenac sodium) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

After observing the response to initial therapy with Voltaren (diclofenac sodium) , the dose and frequency should be adjusted to suit an individual patient's needs.

For the relief of osteoarthritis, the recommended dosage is 100-150 mg/day in divided doses (50 mg b.i.d. or t.i.d., or 75 mg b.i.d.).

For the relief of rheumatoid arthritis, the recommended dosage is 150-200 mg/day in divided doses (50 mg t.i.d. or q.i.d., or 75 mg b.i.d.).

For the relief of ankylosing spondylitis, the recommended dosage is 100-125 mg/day, administered as 25 mg q.i.d., with an extra 25-mg dose at bedtime if necessary.

Different formulations of diclofenac [Voltaren® (diclofenac sodium enteric-coated tablets); Voltaren®-XR (diclofenac sodium extended-release tablets); Cataflam® (diclofenac potassium immediate-release tablets)] are not necessarily bioequivalent even if the milligram strength is the same.

Voltaren® (diclofenac sodium enteric-coated tablets)

75 mg - light pink, biconvex, triangular-shaped, enteric-coated tablets (imprinted VOLTAREN (diclofenac sodium) 75 on one side in black ink)

Bottles of 100.................................................NDC 0028-0264-01

Do not store above 30°C (86°F). Protect from moisture.

Dispense in tight container (USP).

REV: February 2011. Manufactured by: Mova Pharmaceuticals Corporation Caguas, Puerto Rico 00726. Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936

Last reviewed on RxList: 4/11/2011
This monograph has been modified to include the generic and brand name in many instances.